These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

180 related articles for article (PubMed ID: 35313093)

  • 41. Low-dose rituximab treatment in a patient with anti-neurofascin-155 IgG4 autoimmune nodopathy.
    Kmezic I; Press R; Glenewinkel H; Doppler K; Appeltshauser L
    J Neuroimmunol; 2024 Apr; 389():578326. PubMed ID: 38422690
    [TBL] [Abstract][Full Text] [Related]  

  • 42. ELectron microscopic abnormality and therapeutic efficacy in chronic inflammatory demyelinating polyneuropathy with anti-neurofascin155 immunoglobulin G4 antibody.
    Kuwahara M; Suzuki H; Oka N; Ogata H; Yanagimoto S; Sadakane S; Fukumoto Y; Yamana M; Yuhara Y; Yoshikawa K; Morikawa M; Kawai S; Okazaki M; Tsujimoto T; Kira JI; Kusunoki S
    Muscle Nerve; 2018 Mar; 57(3):498-502. PubMed ID: 28796305
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Anti-NF155 chronic inflammatory demyelinating polyradiculoneuropathy strongly associates to HLA-DRB15.
    Martinez-Martinez L; Lleixà MC; Boera-Carnicero G; Cortese A; Devaux J; Siles A; Rajabally Y; Martinez-Piñeiro A; Carvajal A; Pardo J; Delmont E; Attarian S; Diaz-Manera J; Callegari I; Marchioni E; Franciotta D; Benedetti L; Lauria G; de la Calle Martin O; Juárez C; Illa I; Querol L
    J Neuroinflammation; 2017 Nov; 14(1):224. PubMed ID: 29145880
    [TBL] [Abstract][Full Text] [Related]  

  • 44. [A case of a 17-year-old male with neurofascin-155 antibody-positive chronic inflammatory demyelinating polyradiculoneuropathy presenting with tremor and ataxia].
    Itaya K; Inoue M; Iizuka N; Shimizu Y; Yuki N; Ichikawa H
    Rinsho Shinkeigaku; 2016 Sep; 56(9):633-6. PubMed ID: 27580761
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Antibodies against the node of Ranvier: a real-life evaluation of incidence, clinical features and response to treatment based on a prospective analysis of 1500 sera.
    Delmont E; Brodovitch A; Kouton L; Allou T; Beltran S; Brisset M; Camdessanché JP; Cauquil C; Cirion J; Dubard T; Echaniz-Laguna A; Grapperon AM; Jauffret J; Juntas-Morales R; Kremer LD; Kuntzer T; Labeyrie C; Lanfranco L; Maisonobe T; Mavroudakis N; Mecharles-Darrigol S; Nicolas G; Noury JB; Perie M; Rajabally YA; Remiche G; Rouaud V; Tard C; Salort-Campana E; Verschueren A; Viala K; Wang A; Attarian S; Boucraut J
    J Neurol; 2020 Dec; 267(12):3664-3672. PubMed ID: 32676765
    [TBL] [Abstract][Full Text] [Related]  

  • 46. [A case of anti-neurofascin 155 antibody-positive combined central and peripheral demyelination successfully treated with plasma exchange].
    Shimizu M; Koda T; Nakatsuji Y; Ogata H; Kira JI; Mochizuki H
    Rinsho Shinkeigaku; 2017 Jan; 57(1):41-44. PubMed ID: 28025411
    [TBL] [Abstract][Full Text] [Related]  

  • 47. [A case of neurofascin-155 antibody-positive chronic inflammatory demyelinating polyradiculoneuropathy successfully treated with Cyclosporine A].
    Sato D; Ogata H; Kuwahara M; Kira J; Kusunoki S; Suzuki Y
    Rinsho Shinkeigaku; 2020 Aug; 60(8):533-537. PubMed ID: 32641627
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Acute-onset chronic inflammatory demyelinating polyneuropathy with anti-neurofascin-155 antibodies and bilateral facial nerve enhancement.
    Caetano A; Ladeira F; Fernandes M; Pires P; Medeiros E
    J Neuroimmunol; 2019 Nov; 336():577026. PubMed ID: 31450157
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Case Report: Telitacicept in treating a patient with NF155+ autoimmune nodopathy: a successful attempt to manage recurrent elevated sero-anti-NF155 antibodies.
    Ren Y; Chen S; Yang H
    Front Immunol; 2023; 14():1279808. PubMed ID: 37965304
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Paranodal dissection in chronic inflammatory demyelinating polyneuropathy with anti-neurofascin-155 and anti-contactin-1 antibodies.
    Koike H; Kadoya M; Kaida KI; Ikeda S; Kawagashira Y; Iijima M; Kato D; Ogata H; Yamasaki R; Matsukawa N; Kira JI; Katsuno M; Sobue G
    J Neurol Neurosurg Psychiatry; 2017 Jun; 88(6):465-473. PubMed ID: 28073817
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Auto-antibodies to contactin-associated protein 1 (Caspr) in two patients with painful inflammatory neuropathy.
    Doppler K; Appeltshauser L; Villmann C; Martin C; Peles E; Krämer HH; Haarmann A; Buttmann M; Sommer C
    Brain; 2016 Oct; 139(Pt 10):2617-2630. PubMed ID: 27474220
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Anti-NF155/NF186 IgG4 Antibody Positive Autoimmune Nodopathy.
    Wang L; Pan J; Meng H; Yang Z; Zeng L; Liu J
    Brain Sci; 2022 Nov; 12(11):. PubMed ID: 36421911
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Anti-pan-neurofascin antibodies induce subclass-related complement activation and nodo-paranodal damage.
    Appeltshauser L; Junghof H; Messinger J; Linke J; Haarmann A; Ayzenberg I; Baka P; Dorst J; Fisse AL; Grüter T; Hauschildt V; Jörk A; Leypoldt F; Mäurer M; Meinl E; Michels S; Motte J; Pitarokoili K; Stettner M; Villmann C; Weihrauch M; Welte GS; Zerr I; Heinze KG; Sommer C; Doppler K
    Brain; 2023 May; 146(5):1932-1949. PubMed ID: 36346134
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Anti-neurofascin autoantibody and demyelination.
    Kira JI; Yamasaki R; Ogata H
    Neurochem Int; 2019 Nov; 130():104360. PubMed ID: 30582947
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Destruction of paranodal architecture in inflammatory neuropathy with anti-contactin-1 autoantibodies.
    Doppler K; Appeltshauser L; Wilhelmi K; Villmann C; Dib-Hajj SD; Waxman SG; Mäurer M; Weishaupt A; Sommer C
    J Neurol Neurosurg Psychiatry; 2015 Jul; 86(7):720-8. PubMed ID: 25694474
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Autoantibodies in chronic inflammatory demyelinating polyradiculoneuropathy.
    Pascual-Goñi E; Martín-Aguilar L; Querol L
    Curr Opin Neurol; 2019 Oct; 32(5):651-657. PubMed ID: 31306213
    [TBL] [Abstract][Full Text] [Related]  

  • 57. [Autoantibodies in Chronic Inflammatory Demyelinating Polyneuropathy].
    Koga M
    Brain Nerve; 2018 Apr; 70(4):395-403. PubMed ID: 29632287
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Contactin-1 and Neurofascin-155/-186 Are Not Targets of Auto-Antibodies in Multifocal Motor Neuropathy.
    Doppler K; Appeltshauser L; Krämer HH; Ng JK; Meinl E; Villmann C; Brophy P; Dib-Hajj SD; Waxman SG; Weishaupt A; Sommer C
    PLoS One; 2015; 10(7):e0134274. PubMed ID: 26218529
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Polyneuropathies and chronic inflammatory demyelinating polyradiculoneuropathy in multiple sclerosis.
    Suanprasert N; Taylor BV; Klein CJ; Roforth MM; Karam C; Keegan BM; Dyck PJB
    Mult Scler Relat Disord; 2019 May; 30():284-290. PubMed ID: 30870805
    [TBL] [Abstract][Full Text] [Related]  

  • 60. A Systematic Review and Meta-Analysis of Autoantibodies for Diagnosis and Prognosis in Patients With Chronic Inflammatory Demyelinating Polyradiculoneuropathy.
    Guo X; Tang L; Huang Q; Tang X
    Front Neurosci; 2021; 15():637336. PubMed ID: 34108854
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.